No. of India’s TB patients may be double the estimate: Lancet
India's tuberculosis nightmare could be much worse than feared. A new study analysing the sale of anti-TB medicines across India has estimated that there could be two times more drug-sensitive TB patients than currently assumed. While it was assumed that India's annual burden of TB cases stands at roughly 2.2 million a year, the study to be published in The Lancet Infectious Diseases journal on Thursday pegs this number at over 3.8 million in 2014. This excludes drug-resistant TB cases. The study, jointly done by the Indian government, the Imperial College of London and the Bill & Melinda Gates Foundation, confirmed what has long been suspected: more Indian TB patients seek treatment in the private sector than the public sector. Dr Sunil Khaparde, who heads the Central TB Division and is an author of the Lancet study, said, "We realised the number of patients coming to the private sector were underestimated, but the new study looked at medicine sales an...